Boundless Bio (BOLD) Total Current Liabilities (2023 - 2026)

Boundless Bio (BOLD) has reported Total Current Liabilities for 4 consecutive years, with $9.6 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Total Current Liabilities rose 51.2% year-over-year to $9.6 million; the TTM figure through Mar 2026 stood at $9.6 million (up 51.2% YoY), while the FY2025 annual figure was $12.5 million, up 54.11% from the prior year.
• Total Current Liabilities slipped to $9.6 million in Q1 2026 per BOLD's latest filing, from $12.5 million in the prior quarter.
• Across five years, Total Current Liabilities topped out at $12.5 million in Q4 2025 and bottomed at $6.3 million in Q1 2025.
• Historically, Total Current Liabilities has averaged $9.7 million across 4 years, with a median of $9.5 million in 2023.
• On a YoY basis, Total Current Liabilities climbed as much as 54.11% in 2025 and fell as far as 40.45% in 2025.
• Boundless Bio's Total Current Liabilities stood at $9.4 million in 2023, then slipped by 13.08% to $8.1 million in 2024, then jumped by 54.11% to $12.5 million in 2025, then slipped by 23.56% to $9.6 million in 2026.
• Business Quant data shows BOLD's Total Current Liabilities at $9.6 million in Q1 2026, $12.5 million in Q4 2025, and $11.8 million in Q3 2025.